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Sequential Involvement of NFAT and Egr
Transcription Factors in FasL Regulation
cells, macrophages, eosinophils, and basophils, al-
though the function of NFAT in these latter cells remains
unclear (Verweij et al., 1990; Choi et al., 1994; Venkatara-
Jyothi Rengarajan,* Paul R. Mittelstadt,²
Hans W. Mages,³ Andrea J. Gerth,*
Richard A. Kroczek,³ Jonathan D. Ashwell,²
and Laurie H. Glimcher*§k man et al., 1994; Timmerman et al., 1997). In resting
cells, NFAT proteins are present in the cytoplasm in*Department of Immunology and Infectious Diseases
Harvard School of Public Health a phosphorylated state. Activation through the T cell
receptor (TCR) and other stimuli that result in an influxBoston, Massachusetts 02115
²Laboratory of Immune Cell Biology of calcium leads to the dephosphorylation and rapid
translocation of NFAT into the nucleus, where they acti-National Cancer Institute
National Institutes of Health vate a number of genes, including those encoding cyto-
kines, cell surface receptors, signaling molecules, andBethesda, Maryland 20892
³Molecular Immunology other as yet unidentified targets. NFAT dephosphoryla-
tion is mediated by the phosphatase calcineurin, andRobert Koch-Institute
Berlin D-13353 genes regulated by NFAT are thus sensitive to transcrip-
tional inhibition by compounds such as cyclosporin AGermany
§Department of Medicine (CsA) that inhibit calcineurin (Emmel et al., 1989; Kubo
et al., 1994; Beals et al., 1997).Harvard Medical School
Boston, Massachusetts 02115 Analysis of mice harboring single mutations at the
NFATc, NFATp, and NFAT4 loci provided convincing
evidence for some unique functions for each of these
family members, but the immune system phenotypesSummary
observed suggested redundancy among the NFAT pro-
teins. Mice lacking NFATc in the lymphoid system (asThe critical function of NFAT proteins in maintaining
evaluated by RAG-22/2 blastocyst complementation)lymphoid homeostasis was revealed in mice lacking
have mildly impaired proliferation and a decrease in IL-4both NFATp and NFAT4 (DKO). DKO mice exhibit in-
production (Ranger et al., 1998a; Yoshida et al., 1998),creased lymphoproliferation, decreased activation-
while NFATp null mice display T and B cell hyperprolifer-induced cell death, and impaired induction of FasL. The
ation and an increase in Th2-type cytokines (Hodge ettranscription factors Egr2 and Egr3 are potent activa-
al., 1996b; Xanthoudakis et al., 1996; Kiani et al., 1997).tors of FasL expression. Here we find that Egr2 and
Mice lacking NFAT4 have normal cytokine profiles butEgr3 are NFAT target genes. Activation of FasL occurs
have greater numbers of T and B cells in the peripheryvia the NFAT-dependent induction of Egr3, as demon-
with activated/memory phenotypes (Oukka et al., 1998).strated by the ability of exogenously provided NFATp
The critical function of NFATs in maintaining lymphoidto restore Egr-dependent FasL promoter activity in
homeostasis and a balanced immune response becameDKO lymph node cells. Further, Egr3 expression is
strikingly evident from the phenotype of mice lackingenriched in Th1 cells, suggesting a molecular basis
both NFATp and NFAT4 (DKO). DKO mice exhibit a mas-for the known preferential expression of FasL in the
sive lymphoproliferative disorder and extreme activationTh1 versus Th2 subset.
of the Th2 compartment (Ranger et al., 1998b). The
lymphadenopathy and splenomegaly are characterized
by hyperresponsiveness of T cells to proliferative signalsIntroduction
and by increased resistance to activation-induced cell
death (AICD). One gene that could well explain this de-Nuclear factor of activated T cells (NFAT) is a family of
related transcription factors that play a central role in fect in apoptosis is the FasL gene, whose expression
was markedly impaired in these mice (Ranger et al.,regulating the immune response (Durand et al., 1988;
Shaw et al., 1988; Crabtree, 1989; Rao et al., 1997). There 1998b). What was unclear, however, was whether the
are presently four known members of the NFAT family: defective expression of FasL reflected a direct or indi-
NFATp (NFAT1, NFATc2), NFATc (NFAT2, NFATc1), rect requirement for NFAT proteins in driving FasL gene
NFAT3 (NFATc4), and NFAT4 (NFATc3, NFATx), with all transcription.
but NFAT3 being expressed in the immune system Several in vitro studies have demonstrated the in-
(McCaffrey et al., 1993; Northrop et al., 1994; Hoey et volvement of NFAT in FasL transcription (Latinis et al.,
al., 1995; Masuda et al., 1995). NFATp and NFATc are 1997). FasL expression is sensitive to transcriptional
expressed at particularly high levels in peripheral lym- inhibition by CsA and cyclohexamide, and NFAT pro-
phoid organs, and NFAT4 is preferentially expressed in teins can bind to and transactivate the FasL promoter
the thymus. While most studies have focused on the in activated Jurkat cells (Latinis et al., 1997). While these
role of NFAT in T lymphocytes, NFAT proteins are also studies postulate that NFAT may be a direct regulator
expressed in B lymphocytes as well as in NK cells, mast of FasL, it has recently been demonstrated that the CsA-
sensitive early growth response (Egr) transcription fac-
tors Egr3 and Egr2 are also potent activators of FasLk To whom correspondence should be addressed (e-mail: lglimche@
hsph.harvard.edu). expression (Mittelstadt and Ashwell, 1998, 1999). There
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are four members of the Egr family of transcription fac-
tors: Egr1 (Krox24, NGFI-A), Egr2 (Krox20), Egr3 (PILOT),
and Egr4 (NGFI-C) (Crosby et al., 1991; Gashler and
Sukhatme, 1995). They possess highly homologous
DNA-binding domains containing three cys2his2 zinc
fingers and bind to and transactivate transcription from
the consensus sequence GCGGGGGCG (Swirnoff and
Milbrandt, 1995). Very little, however, is known about
the function of Egr proteins in the immune response.
To elucidate the mechanism by which NFATs control
FasL gene transcription in vivo, we have examined the
expression and function of Egr family members in NFAT-
deficient mice. We demonstrate that both Egr2 and Egr3
are NFAT target genes and are also regulated by the
NFAT-interacting protein NIP45 (Hodge et al., 1996a).
While NFATs may play some role in directly transactivat-
ing the FasL gene, our experiments demonstrate that
NFAT-mediated induction of Egr3 and/or Egr2 is essen-
tial for optimal FasL synthesis in vivo. Further, the obser-
Figure 1. Northern Blot Analysis of RNA from CD41 Cells of NFAT-vation that Egr3 expression is enriched in Th1 cells sug-
Deficient Mice
gests a molecular basis for the known preferential
RNA was isolated from CD41 cells from (A) wild-type (lanes 1±4),
expression of FasL in the Th1 versus Th2 subset. DKO (lanes 5±8), (B) NFATp2/2 (lanes 9±12), and NFAT42/2 (lanes
13±16) mice. Purified CD41 cells were stimulated in a primary culture
with plate-bound anti-CD3 and anti-CD28, rested, and restimulatedResults
on day 8 with plate-bound anti-CD3 for 0, 1, 3, and 6 hr. Total RNA
was isolated and analyzed by Northern blot for the presence of Egr,Egr2 and Egr3 Transcription Factors Are Regulated
FasL, and g-actin transcripts as indicated.
by NFATp and NFAT4
We have previously established that the induction of
FasL expression is defective in T cells from DKO mice NFAT4, which can substitute for one another. The re-
maining NFAT family member, NFATc, is likely responsi-(Ranger et al., 1998b). Since both NFATs and Egr pro-
teins have been implicated in the regulation of the FasL ble for the very low but detectable Egr2 and Egr3 expres-
sion observed in the absence of NFATp and NFAT4promoter in vitro, we were interested in examining the
expression of Egr transcripts in vivo in the NFAT DKO (Figure 1A).
mice.
Purified lymph node (LN) CD41 T cells from DKO and Absence of Complexes that Bind to the NFAT Site
in the Egr3 Promoter in Nuclear Extractscontrol wild-type mice were stimulated in vitro with
plate-bound anti-CD3 plus anti-CD28 antibodies, rested from DKO T cells
The promoter region of human Egr3 has recently beenfor 8 days, and then restimulated for 1, 3, and 6 hr with
anti-CD3. RNA isolated from rested and restimulated characterized. A 27 bp region of the promoter was identi-
fied that functionally interacts with NFAT proteins incells was examined by Northern analysis using probes
specific for Egr2 and Egr3. As expected, no transcripts Jurkat cells, and this region was demonstrated to be
responsible for the CsA-sensitive expression of Egr3encoding Egr2 or Egr3 were detected in resting wild-
type or DKO cells, and transcripts for both Egr2 and (Mages et al., 1998). To establish whether the lack of
NFATp and NFAT4 proteins was reflected in reducedEgr3 were rapidly induced in the wild-type samples,
consistent with the known inducible kinetics of the Egr NFAT binding activity to the Egr3 promoter, the 27 bp
region of the Egr3 promoter was used in electrophoreticfamily of transcription factors (Figure 1A). In contrast,
expression of both Egr2 and Egr3 mRNA was barely mobility shift assays (EMSAs), with nuclear extracts pre-
pared from wild-type and DKO T cells stimulated withdetectable in the stimulated DKO CD41 T cells at any
time point after activation. Normal induction of tran- PMA and ionomycin. In nuclear extracts from wild-type
T cells, a complex comprised of NFAT proteins wasscripts encoding Egr1 (Figure 1A), which is not CsA
sensitive, demonstrated that activation by anti-CD3 had detected (Figure 2). This complex contained predomi-
nantly NFATp proteins and, to a much lesser extent,occurred in the DKO T cells. These data demonstrate
that the induction of the Egr2 and Egr3 genes is depen- NFATc proteins, as evidenced from supershifts of the
complex using antibodies specific for NFATp anddent on NFATp and NFAT4 family members.
To determine whether NFAT4 and NFATp could com- NFATc. Nuclear extracts prepared from DKO T cells
lacked NFATp binding activity to the NFAT site in thepensate for each other in the induction of the Egr2 and
Egr3 genes, we examined their expression in LN T cells Egr3 promoter. As in the wild-type extracts, a small
amount of NFATc binding activity was visible (Figure 2).isolated from NFATp2/2 and NFAT42/2 single-deficient
mice. A slight alteration in the kinetics of induction of The presence of normal levels of NFATc in the extracts
was confirmed by Western blot analysis (data notEgr2 and Egr3 compared to wild type was apparent in
the absence of either NFATp or NFAT4, but the magni- shown). These data are consistent with a critical function
for NFATp but not NFATc in controlling Egr3 gene ex-tude of induction was normal (Figures 1A and 1B). Thus,
Egr2 and Egr3 are regulated primarily by NFATp and pression in normal T cells. The in vivo results clearly
Egr3 is NFAT Dependent and Th1 Preferential
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Figure 2. Absence of NFAT-Containing Complexes Bound to the
Egr3 Promoter in DKO Nuclear Extracts
Nuclear extracts were prepared from wild-type (lanes 1±4) and DKO
(lanes 5±8) T cells stimulated for 4 hr with PMA and ionomycin and
used in EMSAs with a 27 bp 32P-labeled oligonucleotide from the
Egr3 promoter. NFAT-containing complexes are indicated by a
bracket. Extracts were incubated with control ascites (lanes 1 and
5), anti-NFATp (lanes 2 and 6), anti-NFATc (lanes 3 and 7), or anti-
NFATp plus anti-NFATc (lanes 4 and 8) for supershift analyses.
indicate a role for NFAT4; however, it has not been possi-
ble for us or others to detect NFAT4 binding activity in
T cell extracts in vitro (Timmerman et al., 1997).
NFATp and NFAT4 Directly Transactivate the Egr3
Promoter and Regulate Egr2 In Vitro
To directly assess the ability of NFATp and NFAT4 to
transactivate the Egr3 promoter, we cotransfected
NFATp and NFAT4 expression plasmids and a luciferase
reporter construct containing bases 22952 to 186 of
the Egr3 promoter (Egr3-luc) into M12 B lymphoma cells.
This region of the promoter has been previously shown
to be transactivated by NFATp in Jurkat cells (Mages
et al., 1998). We have extended these studies to NFAT4.
Overexpression of NFATp and NFAT4 resulted in a 7- and
Figure 3. NFATp and NFAT4 Directly Transactivate the Egr3 Pro-5-fold increase, respectively, in Egr3 promoter activity
moter and Regulate Egr2 In Vitrocompared to the control vector (Figure 3A), indicating
(A) M12 B lymphoma cells were transiently transfected with the Egr3that these NFAT proteins directly control Egr3 expres-
promoter construct (Egr3-luc) and cotransfected with vector controlsion. No additional fold increase was observed when
(pREP4), NFATp, and NFAT4 expression plasmids. Values are re-NFATp and NFAT4 were introduced together (data not
ported as fold increases relative to the basic luciferase reporter.
shown). Transfections were performed five to six times and results are shown
To investigate the role of NFAT proteins in transactiva- as mean fold increase 6 SEM.
(B) 2B4.11 cells were transiently transfected with 2607 Egr2-luction of the Egr2 gene, 2607 to 1344 of the 59 flanking
(wild type), 2341 Egr2-luc, or 2607 Egr2 mut NFAT-luc (with mutatedregion of the Egr2 gene was cloned upstream of a lucifer-
NFAT site). Luciferase assays were performed on unstimulatedase reporter gene (2607 Egr2-luc) and analyzed for in-
transfectants or upon stimulation with plate-bound anti-CD3. Trans-ducibility in the 2B4.11 T cell hybridoma. The 2607 Egr2-
fections were repeated three times and results are shown as fold
luc construct was highly inducible by anti-CD3 (Figure induction on stimulation 6 SEM.
3B). This inducibility was reduced 6- to 7-fold upon trun- (C) M12 B lymphoma cells were transiently transfected with the 2607
Egr2-luc construct and cotransfected with vector control (pREP4),cation of the construct to 2341, which deleted the puta-
NFATp, and NFAT4 expression plasmids. Values are reported astive NFAT site (2341 Egr2-luc), and upon mutation of a
fold increases relative to the basic luciferase reporter. Transfectionsputative NFAT site at position 2362 relative to the ATG
were performed four times and results are shown as mean fold(2607 Egr2 mut-luc). Overexpression of NFATp but not
increase 6 SEM.
NFAT4 resulted in transactivation of the 2607 Egr2-
luc construct by 8-fold (Figure 3C), indicating a role for
NFATp in the regulation of this gene. Thus, NFAT pro-
teins control the regulation of the Egr2 as well as the
Egr3 gene.
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Figure 4. NIP45 Augments NFAT-Driven Transactivation of the Egr3
Promoter
M12 lymphoma cells were transiently transfected as in Figure 3A
with control plasmids or NFATp, NFAT4, and NIP45 expression plas-
mids as indicated. Values are reported as fold increases over the basic
luciferase reporter (pGL2) alone. Transfections were performed five to
six times and results are shown as mean fold increase 6 SEM.
An NFAT-Interacting Protein NIP45 Augments
NFAT-Driven Transactivation of Egr3 Figure 5. NFATp Transactivates the FasL Promoter via Egr3 in Pri-
We have recently isolated a novel protein, NIP45, that mary DKO T Cells
interacts with NFAT proteins to augment NFAT-depen- Primary DKO lymph node cells were transfected as described in
dent IL-4 gene expression (Hodge et al., 1996a). We Experimental Procedures.
Top: Transfection of the full-length 2511 FasL-luc promoter withwished to determine whether NIP45 could also affect the
control vector, NFATp, or EGR3 expression plasmids in the absencetranscriptional activation of other NFAT target genes,
or presence of PMA and ionomycin. Shown is a representative ofspecifically the Egr3 gene. Cotransfection of NIP45 in-
four independent experiments.creased NFATp-driven transactivation of the Egr3 pro-
Bottom: Transfection with a minimal FasL reporter construct con-
moter in M12 cells by 3- to 4-fold and NFAT4-driven taining the FLRE (FLRE-FasL-luc wt) or with a mutated FLRE site
transactivation by 2-fold (Figure 4), which is comparable (FLRE-FasL-luc mut) along with control vectors, NFATp, or EGR3
expression plasmids. Cells were left unstimulated or activated withto its augmentation of IL-4 promoter transactivation.
PMA and ionomycin for 12 hr as indicated. Transfections were per-Thus, in addition to its function in enhancing IL-4 gene
formed four times and results are shown as mean fold increase 6expression, NIP45 interacts with NFAT to augment the
SEM. Values for top and bottom are reported as fold increases overtranscription of another NFAT-regulated gene, Egr3.
the basic luciferase reporter alone (pGL3).
Whether the mechanism by which it accomplishes this
increase will be the same for all NFAT/NIP45 target
genes remains to be established. PMA and ionomycin (Figure 5, top). Coexpression of
NFATp increased the activity of the promoter, especially
in the presence of PMA and ionomycin. In addition, Egr3NFATp Transactivates the FasL Promoter via Egr2
and/or Egr3 in Primary DKO T cells was also able to directly transactivate the full-length
FasL promoter construct (Figure 5, top).A 511 bp of sequence upstream of the FasL gene has
been shown to contain the major 59 regulatory elements To directly assess the role of the FLRE and Egr3 in
the NFAT-dependent regulation of FasL, we expressedrequired for FasL induction. Further, a FasL regulatory
element (FLRE) located from 2214 to 2207 in the FasL a construct containing the FLRE region (2220 to 2205)
upstream of the minimal FasL promoter (FLRE-FasL wt)promoter was identified (Mittelstadt and Ashwell, 1998).
The FLRE bound Egr proteins and was shown to account in primary DKO LN cells. This construct does not contain
any known NFAT binding sites and is transactivatedfor most of the TCR-inducible FasL promoter activity
in murine T cell lines. To directly assess whether the solely by Egr proteins (Mittelstadt and Ashwell, 1998).
Coexpression of NFATp with the FLRE-FasL-luc wt con-transactivation of the FasL promoter by Egr2 and Egr3 is
controlled by NFAT, we expressed a luciferase reporter struct resulted in a 3-fold induction of the reporter in
the absence of stimulation and a 10-fold increase in theplasmid containing the full 511 bp FasL promoter (2511
FasL-luc) in primary LN cells from the DKO. LN cells presence of PMA and ionomycin (Figure 5, bottom). That
NFATp mediates the activation of FasL by directlyfrom DKO mice are deficient in NFATp, NFAT4, Egr2,
and Egr3 proteins and provide an excellent system for upregulating endogenous Egr2 and/or Egr3 was demon-
strated by the near extinction of FasL promoter induc-reconstituting the sequence of events leading to FasL
activation. Transfection of the 2511 FasL-luc reporter tion on mutation of the FLRE (FLRE-FasL-luc mut). Fur-
ther, we again demonstrate that Egr3 can directly induceand control vector into DKO LN cells led to a low level
of activity that was not enhanced by stimulation with FasL activity in DKO T cells. This activity is ablated on
Egr3 is NFAT Dependent and Th1 Preferential
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Figure 6. Egr3 Is Expressed Preferentially in
Th1 Clones and Primary Th1 Cells
(A) Northern blot analysis of RNA from D10
(Th2) and AE7 (Th1) clones. Total RNA was
isolated from unstimulated (U) or clones stim-
ulated for 24 hr with plate-bound anti-CD3
and probed for the presence of Egr3, Egr2,
and g-actin as indicated.
(B) Northern blot analysis of RNA from pri-
mary Th1 and Th2 cells. DO11.10 lymph node
and splenocytes were isolated and stimu-
lated in a primary culture with plate-bound
anti-CD3 under Th1- or Th2-skewing condi-
tions (see Experimental Procedures), rested,
and restimulated on day 7 with anti-CD3 for
4 hr in the absence or presence of CsA. Total
RNA was isolated and probed for the pres-
ence of Egr3, Egr2, FasL, and g-actin as indi-
cated.
mutation of the FLRE site (Figure 5, bottom). Thus, the CsA. Consistent with the pattern of expression observed
in the Th clones, Egr3 was preferentially expressed inprovision of exogenous NFATp to DKO T cells directly
induces endogenous Egr3 and/or Egr2, which then primary Th1 cells, and its expression was markedly re-
duced in cells differentiated along a Th2 pathway. Egr2,transactivates the FasL reporter. These data support
NFAT-dependent regulation of FasL expression via the as above, was expressed in both subsets (Figure 5,
bottom). That the expression of both Egr3 and Egr2 wasinduction of the NFAT target genes Egr2 and Egr3.
blocked by the addition of CsA in both Th1 and Th2
subsets (Figure 6B) was confirmed in three independentEgr3 Is Preferentially Expressed in Th1 Cells
FasL mRNA has been reported to be more abundant in experiments. We conclude that the preferential expres-
sion of Egr3 correlates with the expression of FasL andTh1 than in Th2 clones, and this preferential expression
was postulated to account for the greater sensitivity to suggest that the regulation of FasL by Egr3 may account
for the preferential expression of FasL in Th1 cells.AICD exhibited by Th1 compared to Th2 cells in vitro
(Suda et al., 1995; Varadhachary et al., 1997). The mech-
anism for this differential expression of FasL is unknown. Discussion
One possibility is that transcription factors such as the
NFAT and Egr family members that control FasL expres- We have demonstrated that Egr2 and Egr3 are NFAT-
regulated genes whose expression is severely impairedsion are Th-specific. In previous work, we had deter-
mined that the NFAT proteins were expressed in both in mice lacking functional NFATp and NFAT4 proteins
(Figures 1A and 1B). The demonstration that Egr3 isTh1 and Th2 cells (Ranger et al., 1998b). We therefore
examined the expression patterns of Egr2 and Egr3 in regulated by NFAT in vivo confirms and extends recently
published data on its regulation by NFAT in vitro (MagesTh1 and Th2 cells to test whether these transcription
factors, which control FasL expression, are themselves et al., 1998). Further, we provide evidence that another
Egr family member, Egr2, is also an NFAT-regulateddifferentially expressed in the two Th subsets. RNA was
isolated from unstimulated and anti-CD3-stimulated Th1 target gene. We also show that activation of FasL occurs
via the NFAT-dependent induction of Egr3 and/or Egr2.clone AE7 and Th2 clone D10 and used in Northern
analysis. While Egr2 was expressed at comparable lev- This cascade of gene activation is clearly demonstrated
by the ability of exogenously provided NFATp to restoreels in Th1 and Th2 clones, transcripts encoding Egr3
were only present in the activated Th1 clone AE7 and Egr-dependent FasL promoter activity in DKO LN cells
(Figure 5). The virtual absence of Egr2 and Egr3 resultswere absent in the Th2 clone D10 (Figure 6A). This held
true for the Th1 clones D1.1 and AR5 and the Th2 clone in defective FasL expression, accounting in part for the
defective AICD and subsequent lymphadenopathy inCDC35, with high-level expression of Egr3 in the former
but not in the latter (data not shown). these mice.
Several transcription factors in addition to Egr2 andWe extended this analysis to primary Th1 and Th2
cells. CD41 T cells from the OVA-specific D011.10 Egr3 have been implicated in FasL gene transcription,
including NFAT itself, NF-kB and AP-1 (Kasibhatla et al.,TCRab-transgenic mice were stimulated with anti-CD3
and cultured in vitro under conditions that drive the cells 1998) family members, and more recently, a member of
the Forkhead family of transcription factors, FKHRL1to differentiate along a Th1 or Th2 pathway (Hsieh et
al., 1993). After 8 days in culture, cells were restimulated (Brunet et al., 1999). Of these, only Egr2 and Egr3 have
been demonstrated to be critical for FasL expression,with anti-CD3 for 4 hr in the absence or presence of
Immunity
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as demonstrated by the DKO phenotype and suggested early response gene, in the Th1 versus the Th2 lineage
by previous in vitro studies (Mittelstadt and Ashwell, raises the interesting possibility that Egr3 will control
1998, 1999). Egr3 was shown to bind to the FLRE and the expression of other Th1-restricted genes in addition
transactivate the FasL promoter. This same motif along to FasL. While there has been considerable progress in
with two previously identified sites for NFAT was inde- identifying specific transcription factors such as c-Maf,
pendently identified as a response element for the T cell Stat6, and GATA-3 (Glimcher and Singh, 1999) that direct
activation±induced transcription of FasL (Li-Weber et the development of Th2 cells, much less is known about
al., 1998; Norian et al., 1998). Further, Egr2 and Egr3 factors that control Th1 differentiation. Stat4- and IRF-1-
induced FasL mRNA in HeLa cells, suggesting a direct deficient mice lack Th1 cells, revealing the importance
role in activation of FasL (Mittelstadt and Ashwell, 1998, of these factors in the Th1 differentiation pathway
1999). Our studies provide further evidence that Egr3 (Kaplan et al., 1996; Thierfelder et al., 1996; Lohoff et
and Egr2 regulate the transcription of FasL in vivo and al., 1997; Taki et al., 1997). The only other transcription
provide a link between NFAT and Egr proteins. Since factor reported to date that is restricted to Th1 cells in
NFATp and NFAT4 are expressed constitutively in T its expression is the Ets family member ERM, which is
cells, this finding supports the essential role of the induc- induced by IL-12 in a Stat4-dependent manner (Ouyang
ible transcription factors Egr2 and Egr3 in FasL expres- et al., 1999). However, its specific function is still unclear.
sion, which is dependent on protein synthesis. In con- Examining the role of Egr3 in Th1 cells could thus con-
trast to playing a critical role in the induction of FasL in tribute to a greater understanding of the Th1 differentia-
response to signals through the TCR, Egr2 and Egr3 tion process. Mice lacking Egr3 display sensory ataxia
appear not to be important in regulating IL-2-induced and show defects in muscle spindle formation (Tourtel-
FasL expression (Xiao et al., 1999). Moreover, although lotte and Milbrandt, 1998), but no information is available
Egr2 and Egr3 are important components of TCR- about the integrity of Th1 cells in these animals. Egr3
induced FasL gene regulation, it is likely that coopera- may regulate genes such as cytokines and signaling
tion among the multiple factors involved in FasL expres- molecules that control T helper subset commitment or
sion is needed for optimal gene activation in vivo. In maintenance. Furthermore, insights into mechanisms
particular, it is possible that NFAT proteins play a direct responsible for the Th1-enriched expression of Egr3
(Latinis et al., 1997) as well as an indirect role in driving may be obtained by a careful analysis of the Egr3 pro-
FasL gene expression. moter itself.
What is especially interesting is our finding that Egr3,
in contrast to the other factors implicated in FasL ex- Experimental Procedures
pression, is preferentially expressed in Th1 cells (Figures
6A and 6B). Several groups have described the in- Mice, Cell Lines, and Reagents
NFATp2/2, NFAT42/2, and NFATp 3 4 DKO mice were used at 5±6creased expression of FasL in Th1 versus Th2 cells, but
weeks of age and were maintained in pathogen-free facilities inthe genetic basis for this is unknown. Although the FasL
accordance with the guidelines of the Committee on Animals ofgene can be expressed in the absence of Egr3, as evi-
Harvard Medical School. Wild-type controls were age-matcheddenced by the lower but still present levels of FasL
BALB/c mice. DO11.10 mice were obtained from H. Weiner (Harvard
expression in Th2 cells, we speculate that Egr3 may Medical School) and bred in our pathogen-free facilities as above.
account for the Th1-preferential expression of FasL. FasL Cell lines and primary cells were maintained in complete medium
expression in Egr3-deficient cells is presumably driven containing RPMI 1640 supplemented with 10% fetal calf serum
(HyClone Laboratories), glutamine (2 mM), penicillin (50 U/ml), strep-by the other transcription factors detailed above, espe-
tomycin (50 mg/ml), HEPES (100 mM), and b-ME (50 mM). 2B4.11cially Egr2, which is present in both Th1 and Th2 cells.
is a murine T cell hybridoma and M12 is a B cell lymphoma line. CsAImmediate-early genes encoding transcription factors
was obtained from Sandoz. Recombinant human IL-2 was obtainedsuch as c-fos, c-jun, and Egr-1 are rapidly induced in
from Chiron, recombinant murine IL-4, and IL-12 from DNAX. Anti-
response to mitogenic stimuli in the absence of de novo bodies to NFATc (7A6) and NFATp (G1-D10) were kindly provided
protein synthesis and constitute important early steps by G. Crabtree (Stanford University).
in a sequence of gene±protein interactions that lead to
alterations in gene expression. Similarly, the kinetics of Plasmids
expression and rapid inducibility of the immediate-early The human EGR2 fragment encompassing base pairs 2225 to
21175 (Rangnekar et al., 1990) was amplified by PCR from genomicfactors Egr2 and Egr3 suggest roles for these proteins in
DNA and cloned into pCR2.1 (Invitrogen). Oligonucleotides for PCRcellular proliferation and tissue-specific differentiation.
were as follows: 59-TGACCAGCCACTTCTTTCCACC-39 and 59-CATEgr2 is known to be involved in peripheral myelination
CATTTGCTCCTCGCACAAC-39.and hindbrain patterning (Schneider-Maunoury et al.,
The insert was excised with EcoRV and HindIII and transferred
1993), and Egr2 proteins upregulate the Hoxa-2 and via Sma1 and HindIII into pGL3 (Promega) to generate 2607 Egr2-
Hoxb-2 genes that are expressed in developing rhom- luc. The 59 truncation to 2341 was made by excising an EcoRI
bomeres of the hindbrain (Nonchev et al., 1996). Egr3 fragment from the plasmid. The putative NFAT site at 2362 was
mutated using overlapping oligonucleotides to generate 2607 Egr2is highly expressed in developing but not adult muscle
mut NFAT-luc.spindles and is necessary for spindle-specific morpho-
Upper: CGCCTTTTTTGATCAGTCCCAGAGAACCGGAATgenesis (Tourtellotte and Milbrandt, 1998). Within the
Lower: TGGGACTGATCAAAAAAGGCGAAGATCCGGimmune system, it is thus conceivable that Egr2 and The region 22952 to 186 of the Egr2 promoter was cloned up-
Egr3 regulate the transcription of genes critical for the stream of the pGL2 vector as described (Mages et al., 1998).
immune response and function in regulating tissue-spe-
cific differentiation, lymphoid proliferation, and homeo- CD41 T Cell Purification and In Vitro Cultures
stasis. CD41 T cells were purified from lymph nodes (LN) of wild-type and
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